About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Pharmacogenomics
›
Top Articles
Pharmacogenomics
Pharmacology
,
Biology
,
Genetics
2.6
(top 7%)
Impact Factor
2.9
(top 7%)
extended IF
93
(top 4%)
H-Index
2.4K
authors
2.6K
papers
61K
citations
5.4K
citing journals
36.2K
citing authors
Most Cited Articles of Pharmacogenomics
Title
Year
Citations
ABC multidrug transporters: structure, function and role in chemoresistance
2008
734
CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants
2002
597
Solexa Ltd
2004
562
High-resolution DNA melting analysis for simple and efficient molecular diagnostics
2007
493
Analysis of the adult human plasma metabolome
2008
343
HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis
2008
317
Metabolic fingerprinting as a diagnostic tool
2007
313
Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations
2008
299
Rationale and design of the LURIC study--a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease
2001
267
The Consortium for Metabonomic Toxicology (COMET): aims, activities and achievements
2005
255
Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese
2010
241
The thiopurine S-methyltransferase gene locus -- implications for clinical pharmacogenomics
2002
240
Genetic variability in CYP3A5 and its possible consequences
2004
237
Association of genetic variations in HLA-B region with hypersensitivity to abacavir in some, but not all, populations
2004
235
Polymorphic CYP2B6: molecular mechanisms and emerging clinical significance
2007
229
57 varieties: the human cytochromes P450
2004
227
Recent progress in multiple sequence alignment: a survey
2002
227
HLA-B locus in Caucasian patients with carbamazepine hypersensitivity
2006
224
MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine
2009
212
Role of OATP transporters in the disposition of drugs
2007
206
Toward the 1,000 dollars human genome
2005
205
Meta-analysis in genome-wide association studies
2009
199
Silent SNPs: impact on gene function and phenotype
2007
196
Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population
2004
195
Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms
2008
190
0
1
2
next
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.